“Marine Phospholipid Nanoliposomes’ Potential as Therapy for Inflammatory Bowel Disease in Mice”

https://pubmed.ncbi.nlm.nih.gov/38113752

Marine phospholipid nanoliposomes show promise as a therapeutic approach for inflammatory bowel disease, with demonstrated stability, bioavailability, ability to inhibit inflammation, and safe administration in mice.